GlassScriptPhysician profile
Julia M Thorne
NPI 1013227719
$39,138.87
in general payments reported to CMS, 2019-2025
14 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $275 · 2023: $2,237 · 2024: $9,806 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $3,642 · Travel and Lodging: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,867.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,065.00 |
| Food and Beverage | $3,642.20 |
| Travel and Lodging | $1,924.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38,455.18 | 2023-2025 | |
| Allergan, INC. | $127.34 | 2022 | |
| Redhill Biopharma INC. | $107.77 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.13 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $76.87 | 2021-2022 | |
| Almatica Pharma LLC | $54.47 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $51.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $38.60 | 2021-2022 | |
| Novo Nordisk INC | $37.96 | 2021-2022 | |
| Boston Scientific Corporation | $26.32 | 2025 | Wavewriter Alpha Prime 16 |
| Revance Therapeutics, INC. | $17.78 | 2025 | Daxxify |
| Amgen INC. | $17.43 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.89 | 2022 | |
| Biodelivery Sciences International, INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Thorne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.